Complement's participation in acquired immunity

Journal of Leukocyte Biology

Volumn 72, Issue 2, 2002, Pages 249-261

  Nielsen, Claus Henrik ^a   Leslie, Robert Graham Quinton ^b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

B cell receptor; Classical pathway; Follicular dendritic cells; Immune complexes

Indexed keywords

ANTIGEN; B LYMPHOCYTE RECEPTOR; CD32 ANTIGEN; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3D; FC RECEPTOR;

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; AUTOIMMUNITY; B LYMPHOCYTE; COMPLEMENT SYSTEM; HUMORAL IMMUNITY; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODY FORMATION; ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; ANTIGENS, CD19; AUTOIMMUNITY; B-LYMPHOCYTES; COMPLEMENT ACTIVATION; COMPLEMENT C3B; COMPLEMENT C4; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT SYSTEM PROTEINS; DENDRITIC CELLS; GUINEA PIGS; HUMANS; LYMPHOCYTE ACTIVATION; MACROMOLECULAR SUBSTANCES; MEMBRANE MICRODOMAINS; MICE; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, COMPLEMENT 3D; SIGNAL TRANSDUCTION;

EID: 0036698302     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (191)

1. Pepys, M. B. (1974) Role of complement in induction of antibody production in vivo. Effect of cobra venom factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J. Exp. Med. 140, 126-145.
2. Pepys, M. B. (1976) Role of complement in the induction of immunological responses. Transplant. Rev. 32, 93-120.
3. Böttger, E. C., Hoffmann, T., Hadding, U., Bitter-Suermann, D. (1985) Influence of genetically inherited complement deficiencies on the humoral response in guinea pigs. J. Immunol. 135, 4100-4107.
4. Jackson, C. G., Ochs, H. D., Wedgwood, R. J. (1979) Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N. Engl. J. Med. 300, 1124-1129.
5. Ochs, H. D., Wedgwood, R. J., Frank, M. M., Heller, S. R., Hosea, S. W. (1983) The role of complement in the induction of antibody responses. Clin. Exp. Immunol. 53, 208-216.
6. Böttger, E. C., Metzger, S., Bitter-Suermann, D., Stevenson, G., Kleindienst, S., Burger, R. (1986) Impaired humoral response in complement C3-deficient guinea pigs: absence of a secondary antibody response. Eur. J. Immunol. 16, 1231-1235.
7. O'Neil, K. M., Ochs, H. D., Heller, S. R., Cork, L. C., Morris, J. M., Winkelstein, J. A. (1988) Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J. Immunol. 140, 1939-1945.
8. Heyman, B., Pilström, L., Shulman, M. J. (1988) Complement activation is required for the IgM-mediated enhancement of the antibody response. J. Exp. Med. 167, 1999-2004.
9. Sullivan, K. E. (1998) Complement deficiency and autoimmunity. Curr. Opin. Pediatr. 10, 600-606.
10. Böttger, E. C., Hoffmann, T., Hadding, U., Bitter-Suermann, D. (1986) Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease. J. Clin. Investig. 78, 689-695.
11. Papamichail, M., Gutierrez, C., Embling, P., Johnson, P., Holborow, E. J., Pepys, M. B. (1975) Complement dependence of localisation of IgG in germinal centres. Scand. J. Immunol. 4, 343-347.
12. Chen, L. L., Frank, A. M., Adams, J. C., Steinman, R. M. (1978) Distribution of horseradish peroxidase (HRP)-anti-HRP immune complexes in mouse spleen with special reference to follicular dendritic cells. J. Cell Biol. 79, 184-199.
13. Enriquez-Rincon, F., Klaus, G. G. (1984) Follicular trapping of haptenerythrocyte-antibody complexes in mouse spleen. Immunology 52, 107-116.
14. van den Eertwegh, A. J., Laman, J. D., Schellekens, M. M., Boersma, W. J., Claassen, E. (1992) Complement-mediated follicular localisation of T-independent type-2 antigens: the role of the marginal zone macrophages revisited. Eur. J. Immunol. 22, 719-726.
15. van den Berg, T. K., Dopp, E. A., Daha, M. R., Kraal, G., Dijkstra, C. D. (1992) Selective inhibition of immune complex trapping by follicular dendritic cells with monoclonal antibodies against rat C3. Eur. J. Immunol. 22, 957-962.
16. Heyman, B., Wiersma, E. J., Kinoshita, T. (1990) In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 172, 665-668.
17. Thyphronitis, G., Kinoshita, T., Inoue, K., Schweinle, J. E., Tsokos, G. C., Metcalf, E. S., Finkelman, F. D., Balow, J. E. (1991) Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J. Immunol. 147, 224-230.
18. Gustavsson, S., Kinoshita, T., Heyman, B. (1995) Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J. Immunol. 154, 6524-6528.
19. Hebell, T., Ahearn, J. M., Fearon, D. T. (1991) Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254, 102-105.
20. Dempsey, P. W., Allison, M. E., Akkaraju, S., Goodnow, C. C., Fearon, D. T. (1996) C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271, 348-350.
21. Ahearn, J. M., Fischer, M. B., Croix, D., Goerg, S., Ma, M., Xia, J., Zhou, X., Howard, R. G., Rothstein, T. L., Carroll, M. C. (1996) Disruption of the CD21 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4, 251-262.
22. Molina, H., Holers, V. M., Li, B., Fung, Y., Mariathasan, S., Goellner, J., Strauss-Schoenberg, J., Karr, R. W., Chaplin, D. D. (1996) Markedly impaired humoral response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93, 3357-3361.
23. Fischer, M. B., Ma, M., Goerg, S., Zhou, X., Xia, J., Finco, O., Han, S., Kelsoe, G., Howard, R. G., Rothstein, T. L., Kremmer, E., Rosen, F. S., Carroll, M. C. (1996) Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157, 549-556.
24. -/- mice: enhanced affinity maturation but impaired antibody persistence. J. Immunol. 164, 4522-4532.
25. Croix, D. A., Ahearn, J. M., Rosengard, A. M., Han, S., Kelsoe, G., Ma, M., Carroll, M. C. (1996) Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183, 1857-1864.
26. Fang, Y., Xu, C., Fu, Y. X., Holers, V. M., Molina, H. (1998) Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160, 5273-5279.
27. Weis, W. I., Taylor, M. E., Drickamer, K. (1998) The C-type lectin superfamily in the immune system. Immunol. Rev. 163, 19-34.
28. Matsushita, M., Fujita, T. (2001) Ficolins and the lectin complement pathway. Immunol. Rev. 180, 78-85.
29. Linehan, S. A., Martinez-Pomares, L., Gordon, S. (2000) Mannose receptor and scavenger receptor: two macrophage pattern recognition receptors with diverse functions in tissue homeostasis and host defence. Adv. Exp. Med. Biol. 479, 1-14.
30. Inada, K. (1980) Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement. Jpn. J. Exp. Med. 50, 13-21.
31. Eads, M. E., Levy, N. J., Kasper, D. L., Baker, C. J., Nicholson-Weller, A. (1982) Antibody-independent activation of C1 by type Ia group B streptococci. J. Infect. Dis. 146, 665-672.
32. Alberti, S., Alvarez, D., Merino, S., Casado, M. T., Vivanco, F., Tomas, J. M., Benedi, V. J. (1996) Analysis of C3 deposition and degradation on Klebsiella pneumoniae. Infect. Immun. 64, 4726-4732.
33. Kaveri, S. V., Lacroix-Desmazes, S., Mouthon, L., Kazatchkine, M. D. (1998) Human natural autoantibodies: lessons from physiology and prospects for therapy. The Immunologist 6, 227-233.
34. Casali, P., Notkins, A. L. (1989) CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol. Today 10, 364-368.
35. Dighiero, G. (1997) Natural antibodies, tolerance, and autoimmunity. Ann. N. Y. Acad. Sci. 815, 182-192.
36. H families. J. Immunol. 142, 4054-4061.
37. Ochsenbein, A. F., Fehr, T., Lutz, C., Suter, M., Brombacher, F., Hengartner, H., Zinkernagel, R. M. (1999) Control of early viral and bacterial distribution and disease by natural antibodies. Science 286, 2156-2159.
38. Ochsenbein, A. F., Zinkernagel, R. M. (2000) Natural antibodies and complement link innate and acquired immunity. Immunol. Today 21, 624-630.
39. Thornton, B. P., Vetvicka, V., Ross, G. D. (1994) Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152, 1727-1737.
40. Thornton, B. P., Vetvicka, V., Ross, G. D. (1996) Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin. Exp. Immunol. 104, 531-537.
41. Pangburn, M. K. (2000) Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement. Immunopharmacology 49, 149-157.
42. Arvieux, J., Yssel, H., Colomb, M. G. (1988) Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology 65, 229-235.
43. Nielsen, C. H., Matthiesen, S., Lyng, I., Leslie, R. G. Q. (1997) The role of complement receptor 1 (CR1, CD35) in determining complex distribution between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes. Immunology 90, 129-137.
44. Boacle, S. A., Morris, M. A., Holers, V. M., Karp, D. R. (1998) Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J. Immunol. 161, 6537-6543.
45. Villiers, M-B., Villiers, C. L., Jacquier-Sarlin, M. R., Gabert, F. M., Journet, A. M., Colomb, M. G. (1996) Covalent binding of C3b to tetanus toxin: influence on uptake/internalisation of antigen by antigen-specific and non-specific B cells. Immunology 89, 348-355.
46. + T cells in healthy individuals. Eur. J. Immunol. 31, 2660-2668.
47. Cherukuri, A., Cheng, P. C., Pierce, S. K. (2001) The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167, 163-172.
48. Jacquier-Sarlin, M. R., Gabert, F. M., Villiers, M-B., Colomb, M. G. (1995) Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology 84, 164-170.
49. Serra, V. A., Cretin, F., Pépin, E., Gabert, F. M., Marche, P. N. (1997) Complement C3b fragment covalently linked to tetanus toxin increases lysosomal sodium dodecyl sulphate-stable HLA-DR dimer production. Eur. J. Immunol. 27, 2673-2679.
50. Santoro, L., Drouet, C., Reboul, A., Mach, J. P., Colomb, M. G. (1994) Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells. Eur. J. Immunol. 24, 1620-1626.
51. Kozono, Y., Abe, R., Kozono, H., Kelly, R. G., Azuma, T., Holers, V. M. (1998) Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic cells. J. Immunol. 160, 1565-1572.
52. Cutler, A. J., Botto, M., Van Essen, D., Rivi, R., Davies, K. A., Gray, D., Walport, M. J. (1998) T cell-dependent immune response in Clq-deficient mice: defective interferon γ production by antigen-specific T cells. J. Exp. Med. 187, 1789-1797.
53. Snapper, C. M., Mcintyre, T. M., Mandler, R., Pecanha, L. M., Finkelman, F. D., Lees, A., Mond, J. J. (1992) Induction of IgG3 secretion by interferon γ: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J. Exp. Med. 175, 1367-1371.
54. Carter, R. H., Spycher, M. O., Ng, Y. C., Hoffman, R., Fearon, D. T. (1988) Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141, 457-463.
55. Fingeroth, J. D., Heath, M. E., Ambrosino, D. M. (1989) Proliferation of resting B cells is modulated by CD21 and CR1. Immunol. Lett. 21, 291-301.
56. Carter, R. H., Fearon, D. T. (1989) Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM. J. Immunol. 143, 1755-1760.
57. Tsokos, G. C., Lambris, J. D., Finkehnan, F. D., Anastassiou, E. D., June, C. H. (1990) Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration. J. Immunol. 144, 1640-1645.
58. Moore, M. D., Cooper, N. R., Tack, B. F., Nemerow, G. R. (1987) Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc. Natl. Acad. Sci. USA 84, 9194-9198.
59. Fingeroth, J. D., Benedict, M. A., Levy, D. N., Strominger, J. L. (1989) Identification of murine complement receptor type 2. Proc. Natl. Acad. Sci. USA 86, 242-246.
60. Matsumoto, A. K., Kopicky-Burd, J., Carter, R. H., Tuveson, D. A., Tedder, T. F., Fearon, D. T. (1991) Intersection of the complement and immune systems: a signal transduction complex of the B lymphocytecontaining complement receptor type 2 and CD19. J. Exp. Med. 173, 55-64.
61. Bradbury, L. E., Kansas, G. S., Levy, S., Evans, R. L., Tedder, T. F. (1992) The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149, 2841-2850.
62. Carter, R. H., Fearon, D. T. (1992) CD19: lowering the threshold for antigen stimulation of B lymphocytes. Science 256, 105-107.
63. Mongini, P. K., Vilensky, M. A., Highet, P. F., Inman, J. K. (1997) The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CD21). J. Immunol. 159, 3782-3791.
64. Dykstra, M. L., Cherukuri, A., Pierce, S. K. (2001) Floating the raft hypothesis for immune receptors: access to rafts controls receptor signaling and trafficking. Traffic 2, 160-166.
65. Stevanova, I., Horejsi, V., Ansotegui, I. J., Knapp, W., Stockinger, H. (1991) GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254, 1016-1019.
66. Simons, K., Ikonen, E. (1997) Functional rafts in cell membranes. Nature 387, 569-572.
67. Ikonen, E. (2001) Roles of rafts in membrane transport. Curr. Opin. Cell Biol. 13, 470-477.
68. Hoessli, D. C., Ilangumaran, S., Soltermann, A., Robinson, P. J., Borisch, B., Nasir-Ud-Din. (2000) Signaling through sphingolipid microdomains of the plasma membrane: the concept of signaling platform. Glycoconj. J. 17, 191-197.
69. Cheng, P. C., Dykstra, M. L., Mitchell, R. N., Pierce, S. K. (1999) A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J. Exp. Med. 190, 1549-1560.
70. Cheng, P. C., Brown, B. K., Song, W., Pierce, S. K. (2001) Translocation of the B cell antigen receptor into lipid rafts reveals a novel step in signaling. J. Immunol. 166, 3693-3701.
71. Cherukuri, A., Cheng, P. C., Sohn, H. W., Pierce, S. K. (2001) The Cd19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity 14, 169-179.
72. Campbell, K. S. (1999) Signal transduction from the B cell antigenreceptor. Curr. Opin. Immunol. 11, 256-264.
73. Baba, Y., Hashimoto, S., Matsushita, M., Wanatabe, D., Kishimoto, T., Kurosaki, T., Tsukada, S. (2001) Blnk mediates Syk-dependent Btk activation. Proc. Natl. Acad. Sci. USA 98, 2582-2586.
74. van Noesel, C. J., Lankester, A. C., van Schijndel, G. M. W., van Lier, R. A. W. (1993) The CD21/CD19 complex on human B cells contains the Src-family kinase Lyn. Int. Immunol. 5, 699-705.
75. Fujimoto, M., Poe, J. C., Jansen, P. J., Sato, S., Tedder, T. F. (1999) CD19 amplifies B lymphocyte signal transduction by regulating Srcfamily protein tyrosine kinase activation. J. Immunol. 162, 7088-7094.
76. Carter, R. H., Doody, G. M., Bolen, J. B., Fearon, D. T. (1997) Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex. J. Immunol. 158, 3062-3069.
77. Buhl, A. M., Cambier, J. C. (1999) Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for C cell antigen receptor-mediated activation of Bruton's tyrosine kinase. J. Immunol. 162, 4438-4446.
78. Brooks, S. R., Li, X., Volonakis, E. J., Carter, R. H. (2000) Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines. J. Immunol. 164, 3123-3131.
79. Doody, G. M., Justement, L. B., Delibrias, C. C., Matthews, R. J., Lin, J., Thomas, M. L., Fearon, D. T. (1995) A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269, 242-244.
80. Adachi, T., Wakabayashi, C., Nakayama, T., Yakura, H., Tsubata, T. (2000) CD72 negatively regulates signaling through the antigen receptor of B cells. J. Immunol. 164, 1223-1229.
81. D'Ambrosio, D., Hippen, K. I., Minskoff, S. A., Mellman, I., Pani, G., Siminovitch, K. A., Cambier, J. C. (1995) Recruitment and activation of PTP1C in negative regulation of antigen signaling by FcγRIIBI. Science 268, 293-296.
82. Muta, T., Kurosaki, T., Misulovin, Z., Sanchez, M., Nussenzweig, M. C., Ravetch, J. V. (1994) A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling. Nature 368, 70-73.
83. Adachi, T., Flaswinkel, H., Yakura, H., Reth, M., Tsubata, T. (1998) The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J. Immunol. 160, 4662-4665.
84. Otipoby, K. L., Draves, K. E., Clark, E. A. (2001) CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1. J. Biol. Chem. 276, 44315-44322.
85. Ono, M., Bolland, S., Tempst, P., Ravetch, J. V. (1996) Role of inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(γ)RIIB. Nature 383, 263-266.
86. Sármay, G., Koncz, G., Pecht, I., Gergely, J. (1997) Fcγ receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cell. Immunol. Lett. 57, 159-164.
87. Hashimoto, A., Hirose, K., Hidetaka, O., Kurosaki, T., Iino, M. (1999) Inhibitory modulation of B cell receptor-mediated mobilization by Src homology domain-containing inositol 5′-phosphatase (SHIP). J. Biol. Chem. 274, 11203-11208.
88. Liu, Q., Oliviera-dos-Santos, A. J., Mariathasan, S., Bouchard, D., Jones, J., Sarao, R., Kozieradzki, I., Ohashi, P. S., Penninger, J. M., Dumont, D. J. (1998) The inositol polyphosphate 5-phosphatase ship is a crucial negative receptor of B cell antigen receptor signaling. J. Exp. Med. 188, 1333-1342.
89. Dustin, L. B., Plas, D. R., Wong, J., Hu, Y. T., Soto, C., Chan, A. C., Thomas, M. L. (1999) Expression of dominant-negative Src-homology domain 2-containing protein tyrosine kinase activity and B cell activation. J. Immunol. 162, 2717-2724.
90. Sato, S., Jansen, P. J., Tedder, T. F. (1997) CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling. Proc. Natl. Acad. Sci. USA 94, 13158-13162.
91. Mizuno, K., Tagawa, Y., Mitomo, K., Arimura, Y., Hatano, N., Katagiri, T., Ogimoto, M., Yakura, H. (2000) Src homology region 2 (SH2) domaincontaining phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells. J. Immunol. 165, 1344-1351.
92. 2+ mobilisation in FcγR-transfected human cells. Int. Immunol. 10, 141-146.
93. Chakravarty, L., Zabel, M. D., Weis, J. J., Weis, J. H. (2002) Depletion of Lyn kinase from the BCR complex and inhibition of B cell activation by excess CD21 ligation. Int. Immunol. 14, 139-146.
94. Fujimoto, M., Bradney, A. P., Poe, J. C., Steeber, D. A., Tedder, T. F. (1999) Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop. Immunity 11, 191-200.
95. 2+ responses. J. Biol. Chem. 276, 44820-44827.
96. Cherukuri, A., Cheng, P. C., Pierce, S. K. (2001) The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167, 163-172.
97. Kozono, Y., Abe, R., Kozono, H., Kelly, R. G., Azuma, T., Holers, V. M. (1998) Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. J. Immunol. 160, 1565-1572.
98. Mongini, P. K. A., Inman, J. K. (2001) Cytokine dependency of human B cell cycle progression elicited by ligands which coengage BCR and the CD21/CD19/CD81 costimulatory complex. Cell. Immunol. 207, 127-140.
99. Kozono, Y., Duke, R. C., Schleicher, M. S., Holers, V. M. (1995) Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic cells from anti-surface IgM-induced apoptosis. Eur. J. Immunol. 25, 1013-1017.
100. Roberts, T., Snow, C. E. (1999) Recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for the antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells. J. Immunol. 162, 4377-4380.
101. Hayakawa, K., Hardy, R. R (2000) Development and function of B-1 cells. Curr. Opin. Immunol. 12, 346-353.
102. Hayakawa, K., Hardy, R. R., Parks, D. R., Herzenberg, L. A. (1983) The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157, 202-218.
103. Hayakawa, K., Hardy, R. R., Honda, M., Herzenberg, L. A., Steinberg, A. D., Herzenberg, L. A. (1984) Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc. Natl. Acad. Sci. USA 81, 2494-2498.
104. Rickert, R. C., Rajewsky, K., Roes, J. (1995) Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376, 352-355.
105. Engel, P., Zhou, L. J., Ord, D. C., Sato, S., Koller, B., Tedder, T. F. (1995) Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3, 39-50.
106. Krop, I., de Fougerolles, A. R., Hardy, R. R., Allison, M., Schlissel, M. S., Fearon, D. T. (1996) Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Immunol. 26, 238-242.
107. Sato, S., Miller, A. S., Howard, M. C., Tedder, T. F. (1997) Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J. Immunol. 159, 3278-3287.
108. Ahearn, J. M., Fischer, M. B., Croix, D., Goerg, S., Ma, M., Xia, J., Zhou, X., Howard, R. G., Rothstein, T. L., Carroll, M. C. (1996) Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4, 251-262.
109. Hasegawa, M., Fujimoto, M., Poe, J. C., Steeber, D. A., Tedder, T. F. (2001) CD19 can regulate B lymphocyte signal transduction independent of complement activation. J. Immunol. 167, 3190-3200.
110. de Fougerolles, A. R., Batista, F., Johnsson, E., Fearon, D. T. (2001) IgM and stromal cell-associated heparan sulfate/heparin as complement-independent ligands for CD19. Eur. J. Immunol. 31, 2189-2199.
111. Fehr, T., Rickert, R. C., Odermatt, B., Roes, J., Rajewsky, K., Hengartner, H., Zinkernagel, R. M. (1998) Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19. J. Exp. Med. 188, 145-155.
112. Chen, Z. J., Wheeler, J., Notkins, A. L. (1995) Antigen-binding B cells and polyreactive antibodies. Eur. J. Immunol. 25, 579-586.
113. -. Eur. J. Immunol. 26, 2916-2923.
114. Chen, Z. J., Wheeler, C. J., Shi, W., Wu, A. J., Yarboro, C. H., Gallagher, M., Notkins, A. L. (1998) Polyreactive antigen-binding B cells are the predominant cell type in the new-born B cell repertoire. Eur. J. Immunol. 28, 989-994.
115. Reynes, M., Aubert, J. P., Cohen, J. H., Audouin, J., Tricottet, V., Diebold, J., Kazatchkine, M. D. (1985) Human follicular dendritic cells express CR1, CR2 and CR3 complement receptor antigens. J. Immunol. 135, 2687-2694.
116. Yoshida, K., van den Berg, T. K., Dijkstra, C. D. (1993) Two functionally different dendritic cells in secondary lymphoid follicles of mouse spleen, as revealed by CR1/2 and FcγRII-mediated immune complex trapping. Immunology 80, 34-39.
117. Vora, K. A., Ravetch, J. V., Manser, T. (1997) Amplified follicular immune complex deposition in mice lacking the Fc receptor γ-chain does not alter maturation of the B cell response. J. Immunol. 159, 2116-2124.
118. Liu, Y. J., Joshua, D. E., Williams, G. T., Smith, C. A., Gordon, J., Maclennan, I. C. (1989) Mechanism of antigen-driven selection in germinal centres. Nature 342, 929-931.
119. Lindhout, E., Mevissen, M. L., Kwekkeboom, J., Tager, J. M., de Groot, C. (1993) Direct evidence that human follicular dendritic cells (FDC) rescue germinal centre B cells from death by apoptosis. Clin. Exp. Immunol. 91, 330-336.
120. Nie, X., Basu, S., Cerny, J. (1997) Immunisation with immune complex alters the repertoire of antigen-reactive B cells in the germinal centres. Eur. J. Immunol. 27, 3517-3525.
121. Apel, M., Berek, C. (1990) Somatic mutations in antibodies expressed by germinal centre B cells early after primary immunisation. Int. Immunol. 2, 813-819.
122. Wu, J., Qin, D., Burton, G. F., Szakal, A. K., Tew, J. G. (1996) Follicular dendritic cell-derived antigen and accessory activity in initiation of memory IgG responses in vitro. J. Immunol. 157, 3404-3411.
123. Fu, Y. X., Molina, H., Matsumoto, M., Huang, G., Min, J., Chaplin, D. D. (1997) Lymphotoxin-α (LTα) supports development of splenic follicular structure that is required for IgG responses. J. Exp. Med. 185, 2111-2120.
124. Fischer, M. B., Goerg, S., Shen, L., Prodeus, A. P., Goodnow, C. C., Kelsoe, G., Carroll, M. C. (1998) Dependence of germinal centre B cells on expression of CD21/CD35 for survival. Science 280, 582-585.
125. Koopman, G., Keehnen, R. M., Lindhout, E., Zhou, D. F., de Groot, C., Pals, S. T. (1997) Germinal centre B cells rescued from apoptosis by CD40 ligation or attachment to follicular dendritic cells, but not by engagement of surface immunoglobulin or adhesion receptors, become resistant to CD95-induced apoptosis. Eur. J. Immunol. 27, 1-7.
126. Liu, Y. J., Cairns, J. A., Holder, M. J., Abbot, S. D., Jansen, K. U., Bonnefoy, J. Y., Gordon, J., MacLennan, I. C. (1991) Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur. J. Immunol. 21, 1107-1114.
127. Kerekes, K., Prechl, J., Bajtay, Z., Mihály, J., Erdei, A. (1998) A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells. Int. Immunol. 10, 1923-1930.
128. Marquart, H. V., Svehag, S-E., Leslie, R. G. Q. (1994) CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes. J. Immunol. 153, 307-315.
129. Yamakawa, M., Imai, Y. (1992) Complement activation in the follicular light zones of human lymphoid tissues. Immunology 76, 378-384.
130. Qin, D., Wu, J., Carroll, M. C., Burton, G. F., Szakal, A. K., Tew, J. G. (1998) Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses. J. Immunol. 161, 4549-4554.
131. Erdei, A., Bajtay, Z., Fábry, Z., Gergely, J. (1988) Appearance of acceptor-bound C3b on HLA-DR positive macrophages and on stimulated U937 cells; inhibition of Fcγ-receptors by the covalently fixed C3 fragments. Mol. Immunol. 25, 295-303.
132. Maison, C. M., Villiers, C. L., Colomb, M. G. (1989) Secretion, cleavage and binding of complement component C3 by the human monocytic cell line, U937. Biochemistry 261, 407-413.
133. Mold, C., Nemerow, G. R., Bradt, B. M., Cooper, N. R. (1988) CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells. J. Immunol. 140, 1923-1929.
134. Olesen, E. H., Johnson, A. A., Damgaard, G., Leslie, R. G. Q. (1998) The requirement of localised, CR2-mediated, alternative pathway (AP) activation of complement for covalent deposition of C3 fragments on normal B cells. Immunology 93, 177-183.
135. Schwendinger, M. G., Spruth, M., Schoch, J., Dierich, M. P., Prodinger, W. M. (1997) A novel mechanism of alternative pathway complement activation accounts for the deposition of C3-fragments on CR2-expressing homologous cells. J. Immunol. 158, 5455-5463.
136. Leslie, R. G. Q. (1999) The influence of complement receptor type 1 (CD35) and decay-accelerating factor (CD55) on complement receptor type 2- (CD21) mediated alternative pathway activation by B cells. Immunology 97, 371-373.
137. Nielsen, C. H., Marquart, H. V., Prodinger, W. M., Leslie, R. G. Q. (2001) CR2-mediated activation of the complement alternative pathway results in formation of membrane attack complexes on the human B cell surface. Immunology 104, 418-422.
138. Nielsen, C. H., Pedersen, M. L., Marquart, H. V., Prodinger, W. M., Leslie, R. G. Q. (2002) The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and MAC formation on normal peripheral human B cells. Eur. J. Immunol. 32, 1359-1367.
139. Fischer, E., Delibrias, C., Kazatchkine, M. D. (1991) Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol. 146, 865-869.
140. Sheerin, N. S., Springall, T., Carroll, M. C., Hartley, B., Sacks, S. H. (1997) Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice. Clin. Exp. Immunol. 110, 403-409.
141. Wang, Y., Kristan, J., Hao, L., Lenkoski, C. S., Shen, Y., Matis, L. A. (2000) A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J. Immunol. 164, 4340-4347.
142. Colten, H. R. (1994) Immunology. Drawing a double-edged sword. Nature 371, 474-475.
143. Kaya, Z., Afanasyeva, M., Wang, Y., Dohmen, K. M., Schlichting, J., Tretter, T., Fairweather, D., Holers, V. M., Rose, N. R. (2001) Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat. Immunol. 2, 739-745.
144. Sheerin, N. S., Springall, T., Abe, K., Sacks, S. H. (2001) Protection and injury: the differing roles of complement in the development of glomerular injury. Eur. J. Immunol. 31, 1255-1260.
145. Morgan, B. P., Walport, M. J. (1991) Complement deficiency and disease. Immunol. Today 12, 301-306.
146. Robson, M. G., Walport, M. J. (2001) Pathogenesis of systemic lupus erythematosus (SLE). Clin. Exp. Allergy 31, 678-685.
147. Lahita, R. G. (1999) The clinical presentation of systemic lupus erythematosus. In Systemic Lupus Erythematosus (R. G. Lahita, ed.), San Diego, Academic, 325-336.
148. Levinson, A. I., Dziarski, A., Pincus, T., deHoratius, R. J., Zweiman, B. (1981) Heterogeneity of polyclonal B-cell activity in systemic lupus erythematosus. J. Clin. Lab. Immunol. 5, 17-22.
149. Gross, J. A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. R., Madden, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C., Moore, M., Littau, A., Grossman, A., Haugen, H., Foley, K., Blumberg, H., Harrison, K., Kindsvogel, W., Clegg, C. H. (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404, 995-999.
150. Fritzler, M. J., Andrade, L. (1999) Antibodies to non-histone antigens in systemic lupus erythematosus. In Systemic Lupus Erythematosus (R. G. Lahita, ed.), San Diego, Academic, 247-268.
151. Chan, O. T., Hannum, L. G., Haberman, A. M., Madaio, M. P., Shlomchik, M. J. (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189, 1639-1648.
152. null mice. J. Exp. Med. 184, 2049-2053.
153. Serreze, D. V., Fleming, S. A., Chapman, H. D., Richard, S. D., Leiter, E. H., Tisch, R. M. (1998) B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161, 3912-3918.
154. Falcone, M., Lee, J., Patstone, G., Yeung, B., Sarvetnick, N. (1998) B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J. Immunol. 161, 1163-1168.
155. Edwards, J. C., Cambridge, G. (2001) Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology 40, 205-211.
156. Takemura, S., Klimiuk, P. A., Braun, A., Goronzy, J. J., Weyand, C. M. (2001) T cell activation in rheumatoid synovium is B cell dependent. J. Immunol. 167, 4710-4718.
157. Siegert, C., Daha, M., Westedt, M. L., van der Voort, E., Breedveld, F. (1991) IgG autoantibodies against C1q are correlated with nephritis,
158. Schifferli, J. A., Ng, Y. C., Peters, D. K. (1986) The role of complement and its receptor in the elimination of immune complexes. N. Engl. J. Med. 315, 488-495.
159. Fearon, D. T. (1980) Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J. Exp. Med. 152, 20-30.
160. Chevalier, J., Kazatchkine, M. D. (1989) Distribution in clusters of complement receptor type one (CR1) on human erythrocytes. J. Immunol. 142, 2031-2036.
161. Bogers, W. M., Stud, R. K., Janssen, D. J., van Rooijen, N., van Es, L. A., Daha, M. R. (1991) Kupffer cell depletion in vivo results in preferential elimination of IgG aggregates and immune complexes via specific Fc receptors on rat liver endothelial cells. Clin. Exp. Immunol. 86, 328-333.
162. Davies, K. A., Erlendsson, K., Beynon, H. L. C., Peters, A. M., Steinsson, K., Valdimarsson, H., Walport, M. J. (1993) Splenic uptake of immune complexes in man is complement-dependent. J. Immunol. 151, 3866-3873.
163. Iida, K., Mornaghi, R., Nussenzweig, V. (1982) Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J. Exp. Med. 155, 1427-1438.
164. Walport, M. J., Ross, G. D., Mackworth-Young, C., Watson, J. V., Hogg, N., Lachmann, P. J. (1985) Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin. Exp. Immunol. 59, 547-554.
165. Walport, M., Ng, Y. C., Lachmann, P. J. (1987) Erythrocytes transfused into patients with SLE and hemolytic anemia lose complement receptor type 1 from their cell surface. Clin. Exp. Immunol. 69, 501-507.
166. Nielsen, C. H., Rasmussen, J. M., Voss, A., Junker, P., Leslie, R. G. Q. (1998) Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes. Arthritis Rheum. 41, 613-622.
167. Nielsen, C. H., Antonsen, S., Matthiesen, S. H., Leslie, R. G. Q. (1997) The roles of complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) in the regulation of the immune complex-elicited respiratory burst of polymorphonuclear leukocytes in whole blood. Eur. J. Immunol. 27, 2914-2919.
168. Medof, M. E., Iida, K., Mold, C., Nussenzweig, V. (1982) Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J. Exp. Med. 156, 1739-1754.
169. Casciola-Rosen, L. A., Anhalt, G., Rosen, A. (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317-1330.
170. Korb, L. C., Ahearn, J. M. (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158, 4525-4528.
171. Taylor, P. R., Carugati, A., Fadok, V. A., Cook, H. T., Andrews, M., Carroll, M. C., Savill, J. S., Henson, P. M., Botto, M., Walport, M. J. (2000) A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells. J. Exp. Med. 192, 359-366.
172. Botto, M., Dell'Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., Walport, M. J. (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19, 56-59.
173. Grabar, P. (1975) Hypothesis. Auto-antibodies and immunological theories: an analytical review. Clin. Immunol. Immunopathol. 4, 453-466.
174. Lutz, H. U., Bussolino, F., Flepp, R., Fasler, S., Stammler, P., Kazatchkine, M. D., Arese, P. (1987) Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc. Natl. Acad. Sci. USA 84, 7368-7372.
175. Ehrenstein, M. R., Cook, H. T., Neuberger, M. S. (2000) Deficiency in serum immunoglobulin (Ig) M predisposes to development of IgG autoantibodies. J. Exp. Med. 191, 1253-1258.
176. Boes, M., Schmidt, T., Linkemann, K., Beaudette, B. C., Marshak-Rothstein, A., Chen, J. (2000) Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA 97, 1184-1189.
177. Carroll, M. C. (2000) The role of complement in B cell activation and tolerance. Adv. Immunol. 74, 61-88.
178. Carroll, M. C. (2001) Innate immunity in the etiopathology of autoimmunity. Nat. Immunol. 2, 1089-1090.
179. Prodeus, A. P., Goerg, S., Shen, L. M., Pozdnykova, O. O., Chu, L., Alicot, E., Goodnow, C. C., Carroll, M. C. (1998) A critical role for complement in maintenance of self-tolerance. Immunity 9, 721-731.
180. Borrero, M., Clarke, S. H. (2002) Low-affinity anti-Smith antigen B cells are regulated by anergy as opposed to developmental arrest or differentiation to B-1. J. Immunol. 168, 13-21.
181. Santulli-Marotto, S., Qian, Y., Ferguson, S., Clarke, S. H. (2001) Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-Ipr/Ipr mice: altered differentiation and an accelerated response. J. Immunol. 166, 5292-5299.
182. Qian, Y., Santiago, C., Borrero, M., Tedder, T. F., Clarke, S. H. (2001) Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds. J. Immunol. 166, 2412-2419.
183. Hayakawa, K., Asano, M., Shinton, S. A., Gui, M., Allman, D., Stewart, C. L., Silver, L., Hardy, R. R. (1999) Positive selection of natural autoreactive B cells. Science 285, 113-116.
184. Kenny, J. J., Lustig, A., Longo, D. L. (2000) Positive selection of low affinity autoreactive B cells. Curr. Top. Microbiol. Immunol. 252, 39-45.
185. Benoist, C., Mathis, D. (2001) Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2, 797-801.
186. Rifkin, I. R., Leadbetter, E. A., Beaudette, B. C., Kiani, C., Monestier, M., Shlomchik, M. J., Marshak-Rothstein, A. (2000) Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells. J. Immunol. 165, 1626-1633.
187. Bickerstaff, M. C., Botto, M., Hutchinson, W. L., Herbert, J., Tennent, G. A., Bybee, A., Mitchell, D. A., Cook, H. T., Butler, P. J., Walport, M. J., Pepys, M. B. (1999) Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 5, 852-853.
188. Green, T. D., Newton, B. R., Rota, P. A., Xu, Y., Robinson, H. L., Ross, T. M. (2001) C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine 12, 242-248.
189. Ross, T. M., Xu, Y., Green, T. D., Montefiori, D. C., Robinson, H. L. (2001) Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins. AIDS Res. Hum. Retrovir. 17, 829-835.
190. Ross, T. M., Xu, Y., Bright, R. A., Robinson, H. L. (2000) C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 1, 127-131.
191. Test, S. T., Mitsuyoshi, J., Connolly, C. C., Lucas, A. H. (2001) Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide. Infect. Immun. 69, 3031-3040.